RT Journal Article
SR Electronic
T1 A New Device for Rapid Isolation by Size and Characterization of Rare Circulating Tumor Cells
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 427
OP 441
VO 31
IS 2
A1 ISABELLE DESITTER
A1 BELLA S. GUERROUAHEN
A1 NAOUAL BENALI-FURET
A1 JANINE WECHSLER
A1 PASI A. JÄNNE
A1 YANAN KUANG
A1 MASAHIKO YANAGITA
A1 LILIN WANG
A1 JILLIAN A. BERKOWITZ
A1 ROBERT J. DISTEL
A1 YVON E. CAYRE
YR 2011
UL http://ar.iiarjournals.org/content/31/2/427.abstract
AB Background: Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be used for all biological tests applying to the primary cells. Materials and Methods: The ScreenCell® devices are single-use and low-cost innovative devices that use a filter to isolate and sort tumor cells by size. Results: The ScreenCell® Cyto device is able to isolate rare, fixed, tumor cells, with a high recovery rate. Cells are well preserved morphologically. Immunocytochemistry and FISH assays can be performed directly on the filter. The ScreenCell® CC device allows isolation of live cells able to grow in culture. High quality genetic materials can be obtained directly from tumor cells isolated on the ScreenCell® MB device filter. Conclusion: Due to their reduced size, versatility, and capacity to isolate CTCs within minutes, the ScreenCell® devices may be able to simplify and improve non-invasive access to tumor cells.